Moderate Alzheimer Disease clinical trials

Explore recruiting moderate alzheimer disease clinical trials.

Recruiting moderate alzheimer disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Moderate Alzheimer Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Daridorexant to treat insomnia in patients with mild cognitive impairment and mild to moderate Alzheimer disease.

France

Therapeutic use (Phase IV) EU CTIS Study details

Moderate Alzheimer Disease trials by city

Moderate Alzheimer Disease in Toronto Moderate Alzheimer Disease in Vancouver Moderate Alzheimer Disease in Montreal Moderate Alzheimer Disease in Calgary Moderate Alzheimer Disease in Edmonton Moderate Alzheimer Disease in Ottawa Moderate Alzheimer Disease in Winnipeg Moderate Alzheimer Disease in Quebec City Moderate Alzheimer Disease in Hamilton Moderate Alzheimer Disease in Kitchener Moderate Alzheimer Disease in London Moderate Alzheimer Disease in Halifax Moderate Alzheimer Disease in New York Moderate Alzheimer Disease in Los Angeles Moderate Alzheimer Disease in Chicago Moderate Alzheimer Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease